Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac plus low-dose pethidine versus pethidine alone after colectomy
IRCT20190325043107N20Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in postoperative pain comparing Ketorolac + low-dose pethidine with Pethidine (2 arms). Primary endpoint: Pain. Started Jan 2021; status: completed.
02
Drugs
ketorolacpethidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190325043107N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N20.